Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03013504

Completed

A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients (TROIKA)

HER2 Positive Breast Cancer
NCT05426486

Active, not recruiting

A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

HER2-positive Breast Cancer
NCT03683147

Completed

Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer

Stage IV Breast Cancer
NCT04205786

Withdrawn

Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer

HR-positive Breast Cancer
NCT04957212

Completed

Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer

HER2-positive Breast Cancer
NCT06427720

Completed

LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis

Early Diagnosed Breast Cancer
NCT02474641

Active, not recruiting

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer (HYPOSIB)

Early-Stage Breast Carcinoma
NCT04199520

Withdrawn

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

Stage IV Breast Cancer
NCT02476539

Completed

Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

HER2 Positive Breast Cancer
NCT05474690

Withdrawn

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer
NCT05880394

Active, not recruiting

Study of Dotatate Imaging in Breast Cancer

Breast Cancer Stage IV
NCT03818685

Active, not recruiting

Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease (BreastImmune03)

Breast Cancer | Triple Negative Breast Neoplasms
NCT00614172

Completed

Proton Therapy for Early Stage Breast Cancer

Early-Stage Breast Cancer
NCT05769751

Completed

A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

HER2-positive Breast Cancer
NCT05985187

Active, not recruiting

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

HER2-positive Breast Cancer
NCT03735966

Completed

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

HER2 Positive Breast Cancer
NCT04016935

Terminated

EndoPredict® Extended Endocrine Trial (EXET)

Primary Invasive Breast Cancer
NCT04566458

Completed

RWD Study in HER2+ mBC Patients in Third-Line Therapy

Breast Cancer Stage IV
NCT02614833

Completed

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Adenocarcinoma Breast Stage IV
NCT03521245

Active, not recruiting

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

HER2-positive Breast Cancer
NCT03283553

Completed

Involving Family to Improve Communication in Breast Cancer Care

Active Breast Cancer Treatment
NCT04133207

Completed

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (HeCOG/CDKi)

Breast Cancer Stage IV
NCT03102307

Completed

Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)

Early Stage Breast Cancer
NCT00309491

Completed

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Early-stage Breast Cancer
NCT02481128

Completed

Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer

Early-Stage Breast Carcinoma
NCT03933319

Unknown

Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer

HER2-positive Breast Cancer
NCT00455273

Completed

Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer

Locally Advanced Breast Cancer
NCT04033172

Unknown

Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ) (Pyrotinib)

Breast Cancer | HER2-positive Breast Cancer
NCT03881878

Unknown

TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery

HER2-positive Breast Cancer
NCT02142868

No longer available

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Advanced Breast Cancer (Female)
NCT02650193

Completed

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Non-metastatic Breast Cancer
NCT03468374

Unknown

Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT

Early-stage Breast Cancer
NCT03085368

Unknown

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

HER2-positive Breast Cancer
NCT01527487

Completed

Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer

HER2 Negative Breast Cancer
NCT01216319

Completed

Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC) (NRC)

Breast Cancer | Breast Reconstruction | Nipple Reconstruction
NCT01272141

Terminated

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Breast Cancer | Breast Neoplasms | Cancer of the Breast
NCT01380808

Completed

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer
NCT00199212

Completed

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Carcinoma Breast Stage IV
NCT00146549

Completed

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

Breast Cancer | Stage IV Breast Cancer
NCT00395655

Terminated

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Locally Advanced Breast Cancer
NCT06448169

Not yet recruiting

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Triple Negative Breast Cancer | Sensitivity | Neoadjuvant Immunotherapy
NCT02938442

Completed

Vaccination of Triple Negative Breast Cancer Patients

Breast Neoplasms | Triple Negative Breast Cancer
NCT02871791

Completed

Palbociclib With Everolimus + Exemestane In BC

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast Cancer
NCT02694809

Completed

The PROMISE Study: Duavee in Women With DCIS

Postmenopausal | Ductal Breast Carcinoma In Situ
NCT01688388

Completed

Single Fraction Intraoperative Radiotherapy

Stage 0 Breast Carcinoma | Stage I Breast Carcinoma | Stage II Breast Carcinoma | Invasive Ductal and Invasive Lobular Breast Carcinoma
NCT02002533

Completed

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Sleep Disorder | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer
NCT06782698

Active, not recruiting

Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients (HoPEx-Breast)

Early Breast Cancer | Cancer-related Fatigue | Triple Negative Breast Cancer (TNBC) | HER2-Positive Breast Cancer | Quality of Life (QOL)
NCT01905046

Active, not recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ
NCT02598557

Completed

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage 0 Breast Cancer AJCC v6 and v7
NCT07578116

Not yet recruiting

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Positive Breast Carcinoma | Oligometastatic Breast Carcinoma

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations